This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
MDPV: Difference between revisions
>Benzofury m Grammatics |
>White summarysheet template added |
||
| Line 1: | Line 1: | ||
{{headerpanel|{{Template:Warning/MDPV}}{{approval}}}} | {{headerpanel|{{Template:Warning/MDPV}}{{approval}}}} | ||
{{SummarySheet}} | |||
{{SubstanceBox/MDPV}} | {{SubstanceBox/MDPV}} | ||
'''3,4-Methylenedioxypyrovalerone''' (also known as '''MDPV''', '''NRG-1''', and imprecisely as '''Bath Salts''', among many others) is a novel, extremely potent synthetic [[psychoactive class::stimulant]] substance of the [[substituted cathinone|cathinone]] and [[substituted pyrrolidine|pyrrolidine]] chemical classes that produces states of extreme [[Euphoria|stimulant euphoria]], [[disinhibition]], and [[Increased libido|sexual arousal]] when [[Routes of administration|administered]]. MDPV is thought to act primarily as as a [[norepinephrine]]-[[dopamine]] [[reuptake inhibitor]] (NDRI) and possesses powerful euphoric [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim.<ref>US Patent 3478050 - 1-(3',4'-methylenedioxy-phenyl)-2-pyrrolidino-alkanones-(1) | https://www.google.com/patents/US3478050</ref> | '''3,4-Methylenedioxypyrovalerone''' (also known as '''MDPV''', '''NRG-1''', and imprecisely as '''Bath Salts''', among many others) is a novel, extremely potent synthetic [[psychoactive class::stimulant]] substance of the [[substituted cathinone|cathinone]] and [[substituted pyrrolidine|pyrrolidine]] chemical classes that produces states of extreme [[Euphoria|stimulant euphoria]], [[disinhibition]], and [[Increased libido|sexual arousal]] when [[Routes of administration|administered]]. MDPV is thought to act primarily as as a [[norepinephrine]]-[[dopamine]] [[reuptake inhibitor]] (NDRI) and possesses powerful euphoric [[stimulant]] qualities. It was first developed in the 1960s by a team at Boehringer Ingelheim.<ref>US Patent 3478050 - 1-(3',4'-methylenedioxy-phenyl)-2-pyrrolidino-alkanones-(1) | https://www.google.com/patents/US3478050</ref> | ||